BIOMILQ
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $21M
Investors
- 7
About BIOMILQ
BIOMILQ Inc.Founded in 2019 and headquartered in Durham, US, BIOMILQ Inc. specializes in creating human milk through biotechnology.BIOMILQ Inc. is dedicated to developing lab-grown human milk, providing a novel infant feeding option designed to closely replicate the nutritional composition of breast milk. This innovative product targets parents seeking alternatives to traditional infant feeding methods, ensuring a safe and nutritious option for infants.The revenue model for BIOMILQ Inc. is primarily based on partnerships and collaborations with infant formula manufacturers and healthcare providers. The company aims to establish agreements that will allow for the distribution of its lab-grown human milk products, generating revenue through licensing and direct sales once the product is commercialized. The company aims to bring its lab-grown human milk product to market, enhancing infant nutrition options by late 2023. Additionally, BIOMILQ is exploring opportunities to collaborate with healthcare providers and enter new geographical markets, including Europe and Asia-Pacific, by 2024.
Who invested in BIOMILQ
7 investors across 1 round
See all investors in BIOMILQ
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 20, 2021
Amount
$21M
Investors
Questions about BIOMILQ
Who invested in BIOMILQ?
BIOMILQ has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BIOMILQ raised?
BIOMILQ has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BIOMILQ last raise money?
BIOMILQ's most recent round on record is a Series A, in Oct 2021.
What does BIOMILQ do?
BIOMILQ is a biotechnology company.
Where is BIOMILQ headquartered?
BIOMILQ is headquartered in Durham, US.
Which VCs invest in companies like BIOMILQ?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BIOMILQ's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BIOMILQ? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.